Skip to Content

Brasil Pharma SA BPHA3

Morningstar Rating
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

BPHA3 is trading at a 5% discount.
Price
BRL 0.62
Fair Value
BRL 2.45
Uncertainty
Very High
1-Star Price
BRL 1.65
5-Star Price
BRL 7.36
Economic Moat
Gnrpfp
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BPHA3 is a good fit for your portfolio.

Trading Information

Previous Close Price
Day Range
52-Week Range
Bid/Ask
/
Market Cap
Volume/Avg
/

Key Statistics

Price/Earnings (Normalized)
0.07
Price/Sales
8.28
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Brasil Pharma SA is a Brazil-based company primarily engaged in the pharmaceutical retail sector. The company operates in the retail sale of medicines, perfumes, cosmetics, skincare and beauty products and toiletries. The operating segments of the company are Retail sector and Service sector, of which majority of the revenue is generated from the Retail segment. The group has its presence in all the regions of Brazil through its own stores and a franchise network. The owned stores of the company are operated under the Big Ben, Guararapes, District Pharmacy Rosary, Sant'Ana and Mais Economica brands. The company’s franchises operate under the Farmais brand.
Sector
Healthcare
Industry
Pharmaceutical Retailers
Stock Style Box
Small Value
Total Number of Employees
193

Valuation

Metric
BPHA3
Price/Earnings (Normalized)
0.07
Price/Book Value
Price/Sales
8.28
Price/Cash Flow
Price/Earnings
BPHA3

Financial Strength

Metric
BPHA3
Quick Ratio
0.01
Current Ratio
0.06
Interest Coverage
−6.08
Quick Ratio
BPHA3

Profitability

Metric
BPHA3
Return on Assets (Normalized)
1,221.01%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
BPHA3
See how this stock stacks up to its competitors with Morningstar Investor

Pharmaceutical Retailers Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
WBA
Walgreens Boots Alliance IncHwzphpzVbjd$15.2 Bil
RADLY
Raia Drogasil SA ADRTdltnkx$8.3 Bil
ALBHF
Alibaba Health Information Technology LtdCkcyxr$5.7 Bil
ALBBY
Alibaba Health Information Technology Ltd ADRXpdnrr$5.7 Bil
CLCGY
Clicks Group Ltd ADRQcssj$3.6 Bil
TSUSF
Tsuruha Holdings IncTywmydt$3.1 Bil
SGIPF
Sugi Holdings Co LtdNxqn$2.8 Bil
SAEYY
Redcare Pharmacy NV ADRMybw$2.7 Bil
SHPPF
Redcare Pharmacy NVGbhj$2.7 Bil
ZRSEF
DocMorris AGTdtcz$1.1 Bil

Sponsor Center